Total global prescription drug revenue of top 10 companies 2026 projection

In 2026, Pfizer is expected to generate over 51 billion U.S. dollars’ worth of prescription drug revenue, making it the pharmaceutical company with the sixth highest projected Rx drug-based revenue for that specific year. With approximately 51 billion U.S. dollars, Roche is forecast to stand in first place.

GSK

GlaxoSmithKline plc, a British enterprise, based in Brentford, United Kingdom, is one of Europe’s largest pharmaceutical companies. GSK is projected to generate about 41 billion U.S. dollars’ worth of Rx drug revenue in 2026, putting the company in tenth place. In terms of total revenue, they generated close to 34 billion U.S. dollars in 2019, which was the highest revenue amount the company had made between 2006 and 2019.

European pharmaceutical industry

The top ten list based on projected Rx drug revenue included other European pharma companies, such as Sanofi, Roche, and AstraZeneca. In terms of both retail sales and R&D (research & development) spending, the Swiss Roche AG was the European leader in 2018. That year, the pharmaceutical giant generated sales figures of approximately 44 and a half billion U.S. dollars and spent just under ten billion U.S. dollars on R&D.